Related references
Note: Only part of the references are listed.Gender disparities in industry compensation and research payments among neurointerventional surgeons in the USA
Mariam Kyarunts et al.
JOURNAL OF NEUROINTERVENTIONAL SURGERY (2023)
Assessment of Gender Parity: Leadership Representation in Pulmonary and Critical Care Medicine
Emily M. Olson et al.
JOURNAL OF WOMENS HEALTH (2022)
The Diovan scandal in Japan; don't let bygones be bygones
Nanami Murata et al.
JOURNAL OF HUMAN HYPERTENSION (2022)
Pharmaceutical payments to Japanese certified hematologists: a retrospective analysis of personal payments from pharmaceutical companies between 2016 and 2019
Eiji Kusumi et al.
BLOOD CANCER JOURNAL (2022)
Industry payments to allergists and clinical immunologists in the United States during the coronavirus disease 2019 pandemic
Anju Murayama et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2022)
Trend in industry payments to infectious disease physicians in the United States: a seven-year analysis of nonresearch payments from the Open Payments Database between 2014 and 2020
Anju Murayama et al.
CLINICAL MICROBIOLOGY AND INFECTION (2022)
Industry Payments to Physicians Are Kickbacks. How Should Stakeholders Respond?
Aaron Mitchell et al.
JOURNAL OF HEALTH POLITICS POLICY AND LAW (2022)
Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trial
Gary A. Herman et al.
LANCET INFECTIOUS DISEASES (2022)
Industry Relationships With Medical Oncologists: Who Are the High-Payment Physicians?
Kristin Wright et al.
JCO ONCOLOGY PRACTICE (2022)
Gender Disparities in Industry Payments to Urologists
Danielle Velez et al.
UROLOGY (2021)
Are Financial Payments From the Pharmaceutical Industry Associated With Physician Prescribing? A Systematic Review
Aaron P. Mitchell et al.
ANNALS OF INTERNAL MEDICINE (2021)
Trends in Industry Payments to Medical Oncologists in the United States Since the Inception of the Open Payments Program, 2014 to 2019
Elizabeth S. Tarras et al.
JAMA ONCOLOGY (2021)
The Potential Effects of Financial Conflicts of Interest of Speakers at the US Food and Drug Administration's Pulmonary-Allergy Drug Advisory Committee Meetings
Trevor Bickford et al.
CHEST (2021)
Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19
M. P. O'Brien et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Association between industry payments and prescriptions of long-acting insulin: An observational study with propensity score matching
Kosuke Inoue et al.
PLOS MEDICINE (2021)
Gender differences in industry payments among cardiologists
Inbar Raber et al.
AMERICAN HEART JOURNAL (2020)
Association between Opioid Prescribing in Medicare and Pharmaceutical Company Gifts by Physician Specialty
Mara A. G. Hollander et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2020)
Financial ties between leaders of influential US professional medical associations and industry: cross sectional study
Ray Moynihan et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Respiratory research funding is inadequate, inequitable, and a missed opportunity
Sian Williams et al.
LANCET RESPIRATORY MEDICINE (2020)
Trends in Industry Payments to Physicians in the United States From 2014 to 2018
Deborah C. Marshall et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Evaluating the Strength of the Association Between Industry Payments and Prescribing Practices in Oncology
Aaron P. Mitchell et al.
ONCOLOGIST (2019)
Association of Pharmaceutical Manufacturer Payments to Physicians and Prescribing Dosage of Opioids
William Fleischman et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2019)
Financial relationships between neurologists and industry The 2015 Open Payments database
Aditi Ahlawat et al.
NEUROLOGY (2019)
Characteristics of Industry Payments to Ophthalmologists in the Open Payments Database
Dane H. Slentz et al.
JAMA OPHTHALMOLOGY (2019)
Evaluation of Sex Distribution of Industry Payments Among Radiation Oncologists
Julius K. Weng et al.
JAMA NETWORK OPEN (2019)
Types and Distributions of Biomedical Industry Payments to Men and Women Physicians by Specialty, 2015
Kathryn R. Tringale et al.
JAMA INTERNAL MEDICINE (2018)
Industry Payments to Cardiologists An Analysis of the Open Payments Program From 2014 to 2016
Amarnath Annapureddy et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2018)
Addressing Gender Inequality in Our Disciplines: Report from the Association of Pulmonary, Critical Care, and Sleep Division Chiefs
Carey C. Thomson et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2018)
Types and Distribution of Payments From Industry to Physicians in 2015
Kathryn R. Tringale et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Long-term safety of glycopyrrolate/eFlow® CS in moderate-to-very-severe COPD: Results from the Glycopyrrolate for Obstructive Lung Disease via Electronic Nebulizer (GOLDEN) 5 randomized study
Gary T. Ferguson et al.
RESPIRATORY MEDICINE (2017)
Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians' attitudes and prescribing habits: a systematic review
Freek Fickweiler et al.
BMJ OPEN (2017)
Payments by US pharmaceutical and medical device manufacturers to US medical journal editors: retrospective - observational study
Jessica J. Liu et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Payments by US pharmaceutical and medical device manufacturers to US medical journal editors: retrospective - observational study
Jessica J. Liu et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Association of Gender With Financial Relationships Between Industry and Academic Otolaryngologists
Jean Anderson Eloy et al.
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2017)
Distribution and Patterns of Industry-Related Payments to Oncologists in 2014
Deborah C. Marshall et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Industry Ties in Medicine: Insight from the Open Payments Program
Daniel T. Oberlin et al.
MAYO CLINIC PROCEEDINGS (2016)
Disclosure of Industry Payments to Physicians: An Epidemiologic Analysis of Early Data From the Open Payments Program
Deborah C. Marshall et al.
MAYO CLINIC PROCEEDINGS (2016)
Exploring the Industry-Dermatologist Financial Relationship Insight From the Open Payment Data
Hao Feng et al.
JAMA DERMATOLOGY (2016)
Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries
Colette DeJong et al.
JAMA INTERNAL MEDICINE (2016)
Distribution and Patterns of Industry-Related Payments to Oncologists in 2014
Deborah C. Marshall et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Conflicts of interest may affect conclusions of systematic reviews of flu drugs, study indicates
M. McCarthy
BMJ-British Medical Journal (2014)
Act II of the Sunshine Act
Genevieve Pham-Kanter
PLOS MEDICINE (2014)
Research misconduct and scientific integrity: a call for a global forum
Tetsuya Tanimoto et al.
LANCET (2013)
Lessons learned from the gene therapy trial for ornithine transcarbamylase deficiency
James M. Wilson
MOLECULAR GENETICS AND METABOLISM (2009)
Key opinion leaders - Independent experts or drug representatives in disguise?
Ray Moynihan
BRITISH MEDICAL JOURNAL (2008)
Association between competing interests and authors' conclusions: epidemiological study of ramdomised clinical trials published in the BMJ
LL Kjaergard et al.
BMJ-BRITISH MEDICAL JOURNAL (2002)
Share Paper
